Clinical Trial Update: Evaluation of Safety and Parameters of Application Technique

View source ↗

Summary

Clinical trial completion update for a study evaluating the safety and parameters of an application technique in diabetes patients, sponsored by Novo Nordisk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED